Indivior Pharmaceuticals (INDV) Change in Cash (2024 - 2026)

Indivior Pharmaceuticals' Change in Cash history runs 3 years deep, the most recent figure standing at -$20.0 million for Q1 2026.

• On a quarterly basis, Change in Cash fell 137.74% year-over-year to -$20.0 million in Q1 2026; TTM through Mar 2026 was -$197.0 million, a 258.87% decrease from a year earlier, with the FY2025 full-year figure at -$124.0 million, down 4233.33% from the prior year.
• Change in Cash rose to -$20.0 million in Q1 2026 per INDV's latest filing, from -$252.0 million in the prior quarter.
• Across five years, Change in Cash topped out at $136.0 million in Q2 2025 and bottomed at -$252.0 million in Q4 2025.
• The 3-year median for Change in Cash is -$14.0 million (2024), against an average of -$15.7 million.
• Biggest YoY gain for Change in Cash was 177.94% in 2025; the steepest drop was 912.9% in 2025.
• Year by year, Change in Cash stood at $31.0 million in 2024, then slumped by 912.9% to -$252.0 million in 2025, then jumped by 92.06% to -$20.0 million in 2026.
• Per Business Quant, the three latest INDV Change in Cash figures stand at -$20.0 million (Q1 2026), -$252.0 million (Q4 2025), and -$61.0 million (Q3 2025).